Revelation Biosciences Inc.

Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on developing therapies that harness the power of trained immunity for the prevention and treatment of various diseases. Founded in 2020 by industry veterans, the company's product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD), a TLR4 agonist that stimulates the innate immune system. Revelation is currently evaluating Gemini for multiple indications, including the prevention of post-surgical infection (GEMINI-SSI), acute kidney injury (GEMINI-AKI), and chronic kidney disease (GEMINI-CKD).

Revelation is committed to developing safe and effective therapies to address critical unmet medical needs. The company has made significant progress in its preclinical studies, demonstrating the potential of Gemini to protect against infection and reduce organ damage. Revelation is currently in the process of initiating Phase 1 clinical studies to evaluate the safety and efficacy of Gemini in humans. The company is well-positioned to become a leader in the field of trained immunity, with a strong pipeline of promising product candidates and a dedicated team of experts.

Revelation Biosciences is a clinical-stage life sciences company dedicated to harnessing the power of trained immunity to prevent and treat diseases. Their primary focus is on developing therapies based on their proprietary formulation Gemini, a phosphorylated hexaacyl disaccharide (PHAD) that activates the innate immune system. Revelation is currently evaluating Gemini for its potential in treating acute and chronic organ diseases, including acute kidney injury (AKI), chronic kidney disease (CKD), and myocarditis (REVTx-300), as well as preventing and treating hospital-acquired infection (REVTx-100). Their mission is to provide safe and effective therapies that address unmet medical needs in areas with limited treatment options.

Revelation Biosciences promotes a culture that prioritizes compassion, truth, flexibility, resilience, trust, respect, humility, and teamwork. They encourage their employees to be the best they can be, challenge themselves, and embrace data-driven decision making. A sense of urgency is balanced with a commitment to excellence, and fun is an integral part of their work environment.

Revelation Biosciences' approach to diversity, equity, and inclusion is reflected in its commitment to building a diverse board of directors and executive team, reflecting a range of expertise and backgrounds. This commitment extends to its company culture, fostering a respectful and inclusive environment where every employee feels valued and empowered. While specific details of its DEI strategy are not explicitly stated on the website, Revelation's focus on building a diverse leadership team suggests a commitment to ensuring that diverse perspectives are represented in the decision-making process.